| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.11 | 0.7 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |